Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05036109 · ClinicalTrials.gov registry record · NA
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05036109: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT05036109 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05036109, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
To learn if lifestyle changes (such as diet and exercise) combined with daily aspirin and vitamin D can affect the likelihood of advanced colorectal cancer coming back (recurring)
Interventions
- DRUG Aspirin
- OTHER Physical Activity
- DRUG Vitamin D
- DIETARY_SUPPLEMENT Diet
- BEHAVIORAL Behavioral Support Counseling Sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-10-12 |
| Est. Completion | 2026-02-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05036109
The ClinicalTrials.gov registry entry for NCT05036109 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Aspirin is the first listed.
NCT05036109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05036109 about?
NCT05036109 is a clinical study titled "DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease". To learn if lifestyle changes (such as diet and exercise) combined with daily aspirin and vitamin D can affect the likelihood of advanced colorectal cancer coming back (recurring)
What is the current status of trial NCT05036109?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-10-12. Estimated completion is 2026-02-04.
What interventions are being tested in trial NCT05036109?
The interventions under investigation include: Aspirin (DRUG), Physical Activity (OTHER), Vitamin D (DRUG), Diet (DIETARY_SUPPLEMENT), Behavioral Support Counseling Sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05036109?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.